Pronounced antiarrhythmic effects of ischaemic preconditioning--are there possibilities for pharmacological exploitation?
Parratt
J
J
Department of Pharmacology, Albert Szent Gyorgyi Medical School, Szeged, Hungary.
Vegh
A
A
Papp
J G
JG
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D001920:Bradykinin / Q000502:physiology; D006152:Cyclic GMP / Q000502:physiology; D011464:Epoprostenol / Q000502:physiology; D006801:Humans; D017202:Myocardial Ischemia / Q000503:physiopathology*; D009569:Nitric Oxide / Q000502:physiology
D009569:Nitric Oxide; D011464:Epoprostenol; D006152:Cyclic GMP; D001920:Bradykinin